Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Capital Expenditures (2019 - 2026)

Biodesix filings provide 8 years of Capital Expenditures readings, the most recent being $81000.0 for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 9.46% to $81000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $266000.0, a 91.34% decrease, with the full-year FY2025 number at $259000.0, down 91.98% from a year prior.
  • Capital Expenditures hit $81000.0 in Q1 2026 for Biodesix, down from $86000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $7.7 million in Q1 2023 to a low of $48000.0 in Q3 2025.
  • Median Capital Expenditures over the past 5 years was $329000.0 (2022), compared with a mean of $1.8 million.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 2829.77% in 2023 and later crashed 97.35% in 2025.
  • Biodesix's Capital Expenditures stood at $1.9 million in 2022, then surged by 54.61% to $3.0 million in 2023, then plummeted by 71.88% to $839000.0 in 2024, then tumbled by 89.75% to $86000.0 in 2025, then decreased by 5.81% to $81000.0 in 2026.
  • The last three reported values for Capital Expenditures were $81000.0 (Q1 2026), $86000.0 (Q4 2025), and $48000.0 (Q3 2025) per Business Quant data.